{"filings":[{"id":1535596,"accession_number":"0001828318-26-000050","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-07-09T11:35:21+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix appoints former Apple operations leader Michael Vyvoda as COO effective July 29, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Michael Vyvoda, former Apple Director of Product Operations for AirPods, named COO effective July 29, 2026.","Compensation: $440,000 base salary, 60% target bonus, $4M RSUs (25% vest after 12 months, then quarterly), $100K fully vested RSUs.","Vyvoda will lead global manufacturing, supply chain, and operations engineering across Malaysia, Korea, and India facilities.","Enovix reported Q1 2026 revenue of $7.6M (+49% YoY), pipeline >$130M for Korea products, and first commercial order of ~50,000 units for smart eyewear."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1028556,"accession_number":"0001828318-26-000046","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-06-12T20:37:56+00:00","items":["5.07"],"status":"ready","headline":"Enovix 2026 annual meeting results: all director nominees elected, say-on-pay passed, Deloitte ratified","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 8 director nominees re-elected: each received >73M votes for; broker non-votes ~63.7M each.","Say-on-pay approved: 72.7M for, 15.4M against, 1.3M abstain.","Ratification of Deloitte & Touche as auditor: 148.9M for, 2.8M against, 1.4M abstain.","Quorum established with 153.2M shares voted, representing 70.3% of outstanding stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":68645,"accession_number":"0001828318-26-000027","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-05-13T20:18:39+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q1 revenue $7.6M (+49% YoY); starts smart eyewear battery production; advances smartphone qualification","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $7.6M, up 49% YoY, above guidance high end; GAAP net loss $0.18/sh, non-GAAP loss $0.14/sh.","Began commercial production of silicon-anode smart eyewear battery; expects to ship ~50,000 units in 2026.","Smartphone qualification: 72 of 75 battery specs passed; new silicon-specific framework adopted with lead customer.","Launched MX-1 drone cell with 360 Wh/kg; Korea product pipeline exceeds $130M, driven by drone demand.","Cash $582.7M; Q2 guidance revenue $8-9M, non-GAAP EPS loss $(0.13-0.17)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95913,"accession_number":"0001828318-26-000022","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enovix appoints Steve Bakos as SVP Worldwide Sales; aligns with lead smartphone customer on new qualification framework","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Steve Bakos appointed SVP Worldwide Sales, effective May 5, 2026; reports to Chief Business Officer Samira Naraghi.","Bakos previously VP of Corporate Account Sales at Infineon Technologies handling Apple; 35 years semiconductor sales experience.","Aligned with lead smartphone customer on silicon-specific qualification framework that extends testing duration and improves field performance confidence.","Results from updated framework approaching required performance thresholds, addressing a primary structural barrier to qualification.","Growing sales pipelines and increased demand across smartphones, smart eyewear, drone, and defense applications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109342,"accession_number":"0001828318-26-000005","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Enovix Q4 revenue $11.3M, FY revenue $31.8M (+38% YoY); board authorizes $75M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $11.3M (record, up 16% YoY from $9.7M); FY2025 revenue $31.8M (up 38% from $23.1M).","GAAP net loss per share ($0.16) in Q4, ($0.75) for FY; non-GAAP loss per share ($0.14) and ($0.54).","Non-GAAP gross margin improved to 23% in FY2025 from 0.9% in FY2024; cash & marketable securities $621M.","Smartphone qualification progressing; cycle-life high-power testing is key gating item for commercialization.","Board authorized additional $75M share repurchase; Q1 2026 revenue guidance $6.5-7.5M, non-GAAP loss from ops ($29-32M)."],"consensus_eps_estimate":-0.1798,"consensus_eps_actual":-0.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":31821000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109341,"accession_number":"0001628280-26-002494","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Enovix COO retiring Feb 17; preliminary 2025 revenue growth ~38%","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO Ajay Marathe to retire effective Feb 17, 2026; no disagreement cited.","Preliminary unaudited 2025 revenue grew ~38% YoY, driven by Korea battery business.","SVP Kihong Park expands role to lead Global Manufacturing Operations for scale-up.","Ed Casey (ex-Komag, Seagate, ams OSRAM) hired as VP Operations for AME equipment.","Company targeting mass production for smartphones, smart eyewear, and defense."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125818,"accession_number":"0001828318-25-000308","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q3 revenue $8M (+85% YoY), beats guidance; raises Q4 revenue view to $9.5-10.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $8.0M (+85% YoY), above prior guidance $7.5-8.5M; Q4 revenue guidance raised to $9.5-10.5M.","GAAP gross margin improved to 18% (from -15% YoY); non-GAAP gross margin 21%.","GAAP diluted net loss $0.27/sh; non-GAAP diluted net loss $0.14/sh, within guidance range.","Cash, equivalents & marketable securities $648M (vs $201M a year ago) after convertible note issuance and warrant dividend.","Lead smartphone customer advancing AI-1 battery; independent validation as highest energy density; Fab2 yield improvements progressing."],"consensus_eps_estimate":-0.1598,"consensus_eps_actual":-0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":20556000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142567,"accession_number":"0001828318-25-000300","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-09-15T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Enovix closes $360M convertible note offering at 4.75% due 2030; conversion price $11.21","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$360M aggregate principal of 4.75% convertible senior notes due Sept 15, 2030; conversion price $11.21 (22.5% premium over last sale).","Net proceeds ~$348.6M; used ~$45.3M to pay for capped call transactions that reduce dilution.","Capped calls with six, twelve, eighteen, and thirty-six month expirations; cap prices range $16.47–$20.13 (avg 100% premium).","Remaining proceeds earmarked for general corporate purposes, including potential battery-ecosystem acquisitions that may be EBITDA accretive.","Initial purchasers' over-allotment option for additional $60M exercised in full."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142566,"accession_number":"0001828318-25-000295","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enovix completes warrant dividend financing; no financial details disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Enovix updated its investor presentation following the conclusion of its warrant dividend financing.","No specific financial figures, milestones, or guidance changes were provided in the 8-K or exhibit.","The only exhibit content shown is the presentation title 'Investor Overview September 2025'."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142565,"accession_number":"0001828318-25-000293","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-09-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix completes warrant dividend program, raises $232.1M gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Approximately 26.5M warrants exercised, generating $232.1M gross proceeds for Enovix.","Private warrant exercise price adjusted from $11.50 to $10.66 per warrant; 5.5M outstanding.","As of Sept 5, 2025, company repurchased 5,437,556 shares under its buyback program.","CEO says proceeds will accelerate Fab2 production and potential battery ecosystem acquisitions.","Warrants expired and ceased trading on Aug 29, 2025; program concluded."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142564,"accession_number":"0001828318-25-000289","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-08-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix warrants expire Aug 29; price condition met, 12.6M exercised for $110M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Alternate price condition satisfied; warrants expire Aug 29, 2025; trading ends at 4pm ET, exercise deadline 5pm ET.","Approximately 12.6 million warrants cash-exercised at $8.75 each, yielding ~$110.1 million gross proceeds to date.","Unexercised warrants after deadline are void; holders lose all rights.","Notice of guaranteed delivery available for late exercise submissions before 5pm ET Aug 29."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142563,"accession_number":"0001828318-25-000286","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-08-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix warrants early expiration triggered; final exercise Aug 29; $107.5M proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["VWAP exceeded $10.50 triggering early expiration; alternate expiration date set for Aug 29, 2025.","Warrants must be exercised by 5 p.m. ET on Aug 29; trading on Nasdaq ends at 4 p.m. ET.","Approximately 12.3M warrants exercised so far, generating ~$107.5M in gross proceeds.","Exercise price is $8.75 per warrant; each warrant buys one share of ENVX common stock.","Notice of Guaranteed Delivery available for holders who cannot complete exercise on time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142562,"accession_number":"0001828318-25-000281","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix reappoints veteran semiconductor leader Dan McCranie to Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed J. Daniel 'Dan' McCranie to Board effective Aug 12, 2025; Board expands to 8 directors, 6 independent.","McCranie previously served on Enovix Board (resigned Jan 2023); brings 30+ years semiconductor governance and ops experience.","Compensation: $50k annual cash retainer, initial RSU grant of $275k vesting over 3 years, annual RSU of $195k prorated.","Former Chairman of onsemi, Non-Executive Chairman of Freescale; currently SunPower director and EVP of Sales."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142561,"accession_number":"0001828318-25-000273","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q2 revenue $7.5M (+98% YoY); AI-1 platform launched; non-GAAP EPS loss $0.13 beats guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $7.5M beat guidance of $4.5-6.5M; third consecutive quarter of positive gross margin (non-GAAP 31%).","Non-GAAP net loss per share $0.13 better than guidance ($0.15-$0.21); GAAP net loss $0.22.","AI-1 platform launched with first smartphone battery >900 Wh/L; samples shipped to two top smartphone OEMs.","Cash $203.4M; warrant dividend to raise up to $255M; Board authorized $60M share repurchase program.","Q3 guidance: revenue $7.5-8.5M, non-GAAP operating loss $31-35M, non-GAAP EPS loss $0.14-$0.18."],"consensus_eps_estimate":-0.1711,"consensus_eps_actual":-0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":12566000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142560,"accession_number":"0001828318-25-000271","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix stock price triggers potential early warrant expiration as early as Aug 19","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Common stock closed at $15.06, above $10.50 threshold for five trading days.","Warrants (ENVXW) exercisable at $8.75 per share; earliest expiration date Aug 19, 2025.","Company reserves right to set Alternate Expiration Date if stock stays above $10.50 for 20 of 30 days.","CFO Ryan Benton confirms intention to accelerate expiration if condition is met, with follow-on notice.","Warrants remain tradable and exercisable each day through expiration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142559,"accession_number":"0001828318-25-000264","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-21T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Enovix distributes warrant dividend: 1 warrant per 7 shares, exercise $8.75, early expiration if stock >$10.50","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Record date July 17, 2025; distribution date July 21, 2025; one warrant per seven shares held, rounded down.","Each warrant exercisable at $8.75 per share; expires Oct 1, 2026, but early expiration triggered if VWAP ≥ $10.50 for 20 of 30 trading days.","Stock closed at $15.54 on July 18 – if VWAP stays above $10.50, warrants could expire as early as Aug 19, 2025.","Warrants to trade on Nasdaq under ENVXW starting July 22; up to ~29.2M shares reserved upon exercise.","Holders of 3.00% Convertible Notes due 2028 also receive warrants on same ratio (9.1543 per $1,000 face)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142558,"accession_number":"0001828318-25-000252","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enovix issues supplemental FAQ on warrant dividend; warns margin-account holders may miss exercisable warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Record date July 17, 2025; distribution date on/about July 21, 2025; one warrant per 7 shares held.","Approx. 29M warrants to be issued; exercise price $8.75; warrants expected to trade under ENVXW.","Early expiration trigger: VWAP >= $10.50 for 20 of 30 trading days; otherwise expire Oct 1, 2026.","Shares held in margin accounts may be loaned out; holders must transfer to cash account by record date to receive actual exercisable warrants.","Non-U.S. shareholders eligible; call option holders not entitled; last day to buy shares for warrant eligibility is July 16, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142557,"accession_number":"0001828318-25-000225","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-07T23:59:59+00:00","items":["8.01","7.01","9.01"],"status":"ready","headline":"Enovix declares warrant dividend: 1 warrant per 7 shares, $8.75 exercise, up to $253.8M proceeds","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Each common stockholder receives 1 warrant for every 7 shares held as of July 17, 2025 record date.","Warrants exercisable at $8.75/share; if all ~29M warrants exercised, gross proceeds up to $253.8M.","Warrants expire Oct 1, 2026 unless early expiration triggered if stock VWAP >= $10.50 for 20 of 30 trading days.","Warrants expected to trade on Nasdaq under ticker ENVXW shortly after distribution date ~July 21, 2025.","Convertible noteholders also receive warrants on as-converted basis (9.1543 per $1,000 principal)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142556,"accession_number":"0001828318-25-000223","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enovix Q2 rev $7.5M (+98% YoY), beats guidance; GAAP gross profit positive 3rd straight quarter","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $7.5M, up 98% YoY, exceeded guidance of $4.5M-$6.5M.","GAAP gross profit $0.8M; third consecutive quarter of positive GAAP and non-GAAP gross profit.","Non-GAAP operating loss $27.8M beat guid range $31M-$37M; GAAP op loss $43.8M.","Adjusted EBITDA loss $21.4M, ahead of guidance ($23M-$29M) and improved from $26.4M YoY.","Cash $203M after SolarEdge asset acquisition; GAAP net loss per share $0.22, non-GAAP $0.15."],"consensus_eps_estimate":-0.1711,"consensus_eps_actual":-0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":12566000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142555,"accession_number":"0001828318-25-000220","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix authorizes $60M share repurchase program through Dec 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to $60M of common stock; effective June 30, 2025, expires Dec 31, 2026.","Repurchases may be made via open-market or private transactions; timing and amount at company discretion.","Program can be modified, suspended, or discontinued; no obligation to buy any specific number of shares.","CFO Ryan Benton cites confidence in long-term fundamentals and 100% silicon-anode battery technology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160617,"accession_number":"0001828318-25-000209","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Enovix shareholders elect all seven directors, approve say-on-pay and auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected with 64-71M votes for each; broker non-votes were 57.3M.","Advisory vote on executive compensation approved: 55.0M for, 16.6M against, 583,653 abstain.","Ratification of Deloitte as auditor for FY2025 approved with 126.2M for, 1.9M against.","Quorum of 67.5% (129.5M shares) present at the June 12 annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160616,"accession_number":"0001828318-25-000141","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q1 revenue $5.1M, beats guidance midpoint; net loss $0.12/share; guides Q2 revenue $4.5-6.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $5.1M (near high end of guidance); GAAP net loss $23.5M ($0.12 loss per share).","Non-GAAP net loss per share $0.15; Adjusted EBITDA loss $22.2M.","Q2 2025 revenue guidance $4.5-6.5M; non-GAAP operating loss $31-37M.","Acquired SolarEdge assets in South Korea for $10M to expand coating capacity and defense programs.","Appointed Ryan Benton as CFO and Samira Naraghi as CBO."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":5098000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160615,"accession_number":"0001828318-25-000115","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-04-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix appoints Ryan Benton as CFO effective April 14, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ryan Benton was appointed CFO effective April 14, 2025; over 30 years of financial leadership experience.","Compensation includes $425,000 base salary, 60% target bonus, and $4.5M RSU grant vesting over 5 years.","Benton's first public appearance as CFO will be on Q1 2025 earnings call April 30.","CEO states nearing smartphone battery mass production; chairman notes Routejade acquisition benefit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160614,"accession_number":"0001828318-25-000087","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-04-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enovix acquires SolarEdge battery cell manufacturing facility in South Korea","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquires ~330,000 sq ft facility directly adjacent to existing Nonsan City plant; deal expected to close April 2025.","Plans to hire certain SolarEdge Korea personnel in manufacturing, quality, R&D and process engineering.","Projected sales increase in 2025-2026 with higher mix toward defense and industrial applications; expects improved gross margins.","Facility has been operating for over 20 years; acquisition aims to expand capacity and expedite scaled production."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178850,"accession_number":"0001828318-25-000050","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-02-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix reports record Q4 revenue $9.7M; first positive gross margin; smartphone samples shipped","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $9.7M (record), full-year $23.1M, up 202% YoY; first positive GAAP gross margin of $1.1M (11% of sales).","GAAP net loss $37.5M ($0.20 EPS loss); non-GAAP EPS loss $0.11; adjusted EBITDA loss $11.7M improved from -$21.6M Q3.","Cash and equivalents $272.9M at year-end; Q1 2025 guidance: revenue $3.5M-$5.5M, GAAP EPS loss $0.23-$0.29.","Shipped early smartphone battery samples to lead OEM; secured purchase orders from 7 of top 8 smartphone OEMs and an AI/XR leader.","Fab2 in Malaysia completed Site Acceptance Testing for HVM line; first EX-2M samples shipped on schedule."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":23074000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178849,"accession_number":"0001828318-25-000003","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-01-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix appoints Kristina Truong as first SVP & Chief Accounting Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kristina Truong named SVP and Chief Accounting Officer, effective Dec 30, 2024.","Truong, 53, joined Enovix in June 2022; previously Corporate Controller at Spruce Biosciences and Outset Medical.","She will oversee all accounting, controllership, financial reporting, and SOX controls.","Appointment adds new CAO role to support growth across five international geographies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195520,"accession_number":"0001828318-24-000271","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-12-16T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix CFO Farhan Ahmad departs; company initiates search for replacement","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Farhan Ahmad left effective immediately, not due to disagreement with operations or policies.","Company is searching for a new CFO with strong investor relations and transparent communication.","Enovix holds over $250M cash, reduced cost structure, and financial runway for Penang factory ramp.","Executive Chairman T.J. Rodgers commits to more transparent investor communications going forward."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195519,"accession_number":"0001193125-24-249316","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Enovix prices $100M public offering of 10.4M shares at $9.22/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $100M from 10,416,667 shares at $9.22 per share; underwriter option for 1,562,500 additional shares.","Offering expected to close on November 1, 2024, with Cantor Fitzgerald as sole bookrunner.","Net proceeds will fund general corporate purposes, working capital, and Fab2 high-volume manufacturing in Penang, Malaysia.","Shelf registration statement on Form S-3 declared effective August 18, 2023; prospectus supplement filed with SEC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195518,"accession_number":"0001828318-24-000229","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q3 revenue $4.3M, GAAP net loss $22.5M; opens Fab2, secures second smartphone OEM partnership","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4.3M (above guidance midpoint), up from $3.8M Q2; GAAP net loss $22.5M improved from $115.9M Q2.","Opened Fab2 in Malaysia; commenced shipping EX-1M cells; completed UN38.3 safety certification.","Signed development agreement with second leading smartphone OEM for mass production launch in late 2025.","Q4 2024 guidance: revenue $8-10M, GAAP EPS loss $0.23-0.29, adjusted EBITDA loss $19-25M.","Cash $200.9M at quarter-end; on track to reduce cash consumption with Malaysia ops."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":13357000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211788,"accession_number":"0001828318-24-000155","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q2 revenue $3.8M, beats guidance; Malaysia Agility Line producing first batteries","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss $115.9M vs $46.4M in Q1; includes $38.1M restructuring and $33.7M warrant expense.","Non-GAAP EPS loss $0.14; adjusted EBITDA loss $23.1M; cash & equivalents $249.9M at quarter-end.","Signed agreements with California tech company (mixed reality headset) and Fortune 200 firm (IoT).","Second automotive OEM MOU signed in 2024; Malaysia Agility Line operational, Gen2 Autoline FAT done.","Q3 guidance: revenue $3.5-4.5M, GAAP EPS loss $0.30-0.36, non-GAAP EPS loss $0.17-0.23."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.95,"consensus_revenue_estimate":null,"consensus_revenue_actual":9040000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230533,"accession_number":"0001828318-24-000126","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-06-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Enovix stockholders elect all seven directors, approve say-on-pay, ratify Deloitte auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 7 director nominees elected: Rodgers, Atkins, Ebrahimi, Gutmann, Malchow, Reichow, Talluri.","Advisory vote on executive compensation approved with 79% of votes cast in favor (53.6M for, 13.8M against).","Ratification of Deloitte & Touche as independent auditor for FY2024 approved with 112.2M for, 0.7M against.","Broker non-votes of approximately 46M shares on director elections and say-on-pay.","Director Betsy Atkins received 11.1M withheld votes, highest among nominees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230532,"accession_number":"0001828318-24-000062","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q1 revenue $5.3M beats guidance; non-GAAP gross profit positive for first time","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $5.3M (up from $21K YoY) exceeded guidance of $3.5-4.5M; non-GAAP gross profit turned positive.","GAAP EPS loss $0.28; non-GAAP EPS loss $0.31; Adjusted EBITDA loss $26.3M.","Fab2 Gen2 Agility Line FAT complete; EX-1M sampling in Q2; development deal with top-5 smartphone OEM.","Targeting >$35M annual fixed cost cut by year-end; cash $262.4M at quarter-end.","Q2 2024 guidance: revenue $3-4M, adjusted EBITDA loss $26-32M, non-GAAP EPS loss $0.22-0.28."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":5272000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248919,"accession_number":"0001828318-24-000012","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-02-20T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q4 revenue $7.4M, record top line; Fab2 on track for April samples","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $7.4M vs $0.2M Q3 and $1.1M YoY; driven by Routejade acquisition and Army shipments.","Fab2 in Malaysia built 250k sq ft; first silicon samples expected April 2024; Gen2 equipment arriving.","Entered development agreement with a leading automaker for EV battery; collaboration with Group14.","Plans to sample EX-1M smartphone battery in Q2 2024, targeting 1,000 cycles with 100% active silicon anode.","Q1 2024 guidance: revenue $3.5-4.5M, adjusted EBITDA loss $24-31M, EPS loss $0.29-$0.35."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":7644000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266464,"accession_number":"0001828318-23-000202","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q3 revenue $0.2M; cash $371.3M; narrows FY2023 cash use guidance to $110M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $0.2M from U.S. Army cells; GAAP cost of revenue $16.8M; GAAP op. expenses $33.8M.","Cash, equivalents, and short-term investments $371.3M; Q3 operating cash use $28.2M; capex $17.3M.","FY2023 operational cash use forecast lowered to $110M (from $120M); capex to $65M (from $70M).","Completed FAT for one Gen2 production zone; expects all four zones FAT by Jan 2024; first samples by Apr 2024.","Acquired Routejade for electrode coating; Fab1 restructuring reduces annualized cash burn ~$22M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":263000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266463,"accession_number":"0001828318-23-000198","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-10-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix cuts workforce by 185; shifts Fab1 from manufacturing to R&D; misses Q3 cell production guidance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Workforce reduction of ~185 personnel (including over 125 contractors) with restructuring charge of ~$2.5M.","Accelerated depreciation of $36M for Gen1 equipment in Q4 2023–Q1 2024; annualized savings of $22M from restructuring.","Q3 2023 small cell production cut to 24,000 units vs. guidance of 36,000; expected Q3 revenue only ~$0.2M.","Fab1 becomes 'Center for Innovation' for R&D; high-volume manufacturing to shift to Asia.","Strategy pivots from standard cells to custom cells for large customers like smartphone OEMs and U.S. Army."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283703,"accession_number":"0001828318-23-000196","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-09-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix board member Emmanuel Hernandez to retire; Gutmann becomes Audit Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Emmanuel T. Hernandez retires from Enovix board effective Sept. 30, 2023; not due to any disagreement.","Bernard Gutmann appointed Audit Committee Chairman effective Oct. 1, 2023; receives $22,000 annual retainer.","Joseph Malchow appointed to Audit Committee effective Oct. 1, 2023; receives $10,000 annual retainer.","Hernandez joined board in July 2021 when Enovix went public; cited planned retirement from board roles."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283702,"accession_number":"0001828318-23-000193","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-09-20T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Enovix acquires Routejade for ~$16.5M cash + 6.2M shares; accretive, vertical integration","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration of ~6.2M Enovix shares and ~$16.5M cash for 100% of Routejade.","Acquisition verticalizes electrode coating and battery pack manufacturing; expected to reduce future capex by ~$35M.","Routejade is a qualified supplier of coated rolls for Enovix batteries, supporting Fab2 scale-up starting 2024.","Transaction expected to close in Q4 2023 and be immediately accretive; Routejade CEO Kihong Park will continue to run the business.","Establishes Enovix presence in Korea near customers, equipment suppliers, and raw material suppliers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283701,"accession_number":"0001828318-23-000189","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-09-14T23:59:59+00:00","items":["1.01","2.03"],"status":"ready","headline":"Enovix enters deposit agreement to collateralize $70M loan for Malaysia manufacturing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Enovix will deposit cash into a restricted OCBC account equal to OSSB drawdowns under a $70M loan for manufacturing.","No cash deposits expected in quarter ending Oct 1, 2023; future deposits disclosed in financial statements.","Deposit earns variable interest; Enovix can withdraw interest if sufficient collateral remains.","Enovix cannot withdraw deposit without OCBC consent while loan outstanding; additional margin may be required.","Enovix indemnifies OCBC against losses from unenforceability, breach, or recovery failure of the loan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283700,"accession_number":"0001828318-23-000158","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-07-26T23:59:59+00:00","items":["1.01","2.02","9.01"],"status":"ready","headline":"Enovix signs YBS manufacturing deal for $70M funding; Q2 rev $42K, units beat plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["YBS agreement: $100M equipment investment, Enovix 30%/YBS 70% funded by OCBC; 10-year term.","Secured $70M non-dilutive funding for Fab2 in Malaysia; Gen2 Autoline samples targeted April 2024.","Q2 revenue $42K (10,000 cells); GAAP cost of revenue $14.2M, operating expenses $37.7M.","Fab1 produced 22,502 units (beat 18,000 plan); Q3 guidance ~36,000 units.","CapEx forecast lowered from $120M to $70M; cash $409.2M after $150M convertible debenture offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303241,"accession_number":"0001193125-23-178590","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-06-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix names Farhan Ahmad as CFO; outgoing CFO Steffen Pietzke to consult after July 9","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Steffen Pietzke resigns effective July 9, 2023; will provide consulting for up to 6 months in exchange for $400K RSU grant.","Farhan Ahmad appointed CFO effective July 10, 2023; previously VP Investor Relations & Finance Strategy at Micron Technology.","Ahmad receives $380K base salary, 60% target bonus, and $4M RSU vesting 1/5 after 12 months then monthly over 4 years.","Pietzke's severance includes 9 months' base salary, 18-month equity acceleration, and pro-rata bonus; no disagreement cited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303240,"accession_number":"0001193125-23-174501","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-06-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix appoints Joseph Malchow and Bernard Gutmann to board; expands to 8 directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Malchow (HNVR founding partner, ex-Enphase director) and Gutmann (former ON Semi CFO) join board effective June 22, 2023.","Board expands to eight members, six independent; Malchow on Compensation and Nominating committees; Gutmann on Audit.","Each new director receives annual cash retainers: $45k board service plus committee fees ($5k–$7.5k).","RSU grants: $275k vesting quarterly over 3 years plus $100k vesting over 1 year, per Non-Employee Director Compensation Policy.","Malchow served on Enovix's SPAC board (Dec 2020–Jul 2021); Gutmann brings 40 years semiconductor financial leadership."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303239,"accession_number":"0001828318-23-000115","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-06-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Enovix shareholders elect all six director nominees, approve say-on-pay and auditor at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected with majority support; broker non-votes ~40.3M shares.","Say-on-pay proposal approved with 58.0M for, 4.6M against, 286K abstain.","Advisory vote on frequency: 62.0M for one-year, 226K for two, 504K for three.","Ratification of Deloitte as FY2023 auditor approved with 102.7M for, 0.3M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303238,"accession_number":"0001628280-23-013227","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-04-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q1 production beats plan at 12,500 units; GAAP net loss $73.6M, non-GAAP loss $0.20/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Produced 12,500 full-qual units, beating plan of 9,000; 2.8x over Q4 2022's 4,442 units.","Revenue $21,000 from 3,000 qual samples; GAAP net loss $73.6M including $29.2M stock-based comp.","Non-GAAP net loss $31.6M ($0.20 diluted EPS); adjusted EBITDA loss $28.0M.","Closed $172.5M convertible debenture post-quarter; cash $293.8M plus ~$148.4M net proceeds.","Signed non-binding LOI with YBS for Fab 2 in Malaysia; seeking at least $70M non-dilutive financing."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":21000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303237,"accession_number":"0001628280-23-012433","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-04-21T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Enovix closes $172.5M convertible note offering at 3.00% due 2028; net proceeds ~$165.7M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $172.5M of 3.00% Convertible Senior Notes due 2028; includes $22.5M option exercise and $10M affiliate placement.","Conversion price ~$15.61/share, 15% premium over $13.57 close; capped calls entered to reduce dilution.","Net proceeds ~$165.7M after discounts & expenses; to fund second battery plant and Gen2 equipment.","Capped call transactions cap price initially $21.1692/share, 56% premium."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303236,"accession_number":"0001628280-23-011796","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-04-17T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Enovix Q1 Fab-1 output of 12,500 cells beats 9,000 forecast; seeks $70M non-dilutive financing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Produced 12,500 battery cells in Q1 ending Apr 2, 2023, exceeding forecast of 9,000 cells.","Full-year 2023 target of 180,000 wearable-size cells from Fab-1 remains unchanged.","Seeking at least $70 million in non-dilutive financing for next-gen manufacturing line in Penang, Malaysia.","Penang facility based on non-binding LOI with YBS International Berhad at Penang Science Park."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322871,"accession_number":"0001828318-23-000059","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-02-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q4 2022 revenue $1.1M, net loss $11.2M; guides 180K cells in 2023","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2022 revenue $1.1M (service); GAAP net loss $11.2M ($0.07/share); Non-GAAP net loss $29.2M ($0.19/share).","Shipped 4,442 cells in Q4, exceeding internal goal; volume-weighted yield 42.9% (Q3: 16.4%).","Revenue funnel Active Design/Design Win grew 58% sequentially to $669M from $423M.","Guides Q1 2023 production of 9,000 cells (double Q4); full-year 2023 target 180,000 wearable-size cells.","2023 capex guidance $120M; net cash $322.9M; new COO Ajay Marathe appointed."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":6202000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322870,"accession_number":"0001828318-23-000026","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-01-25T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Enovix appoints Gregory Reichow as Compensation Committee chair, adds Audit Committee role","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Gregory Reichow appointed chair of Compensation Committee effective Jan 24, 2023.","Appointed to Audit Committee effective Jan 25, 2023.","Will receive $10,000 annual retainer as Compensation Committee chair, paid quarterly.","Will receive $7,500 annual retainer as Audit Committee member, paid quarterly."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322869,"accession_number":"0001828318-23-000020","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-01-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Enovix CTO to retire, CCO resigns; Ralph Schmitt appointed new CCO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CTO Ashok Lahiri retiring effective Feb 1, 2023; remains as advisory board lead.","GM & CCO Cameron Dales resigning effective same date; both departures amicable.","Ralph Schmitt, current SVP Sales, named Chief Commercial Officer effective Feb 1.","Lahiri receives 9-mo salary severance, 36-mo COBRA, full equity acceleration.","Dales receives 9-mo salary, 9-mo COBRA, 18-mo equity acceleration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322868,"accession_number":"0001193125-23-012080","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-01-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director John D. McCranie resigns from Enovix board effective Jan 20","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John D. McCranie resigned from the Board effective January 20, 2023.","He also stepped down from the Audit and Compensation Committees, where he served as chair.","Resignation was for personal reasons, not due to any disagreement with the Company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322866,"accession_number":"0001828318-23-000009","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K/A","filed_at":"2023-01-18T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Enovix CEO Harrold Rust retires; Raj Talluri named successor; separation details disclosed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Harrold Rust resigns as CEO, President, and Board member effective Jan 18, 2023; remains employee through Feb 1.","Rust receives severance: 12 months base salary, 36 months COBRA, accelerated equity vesting, prorated target bonus.","Dr. Raj Talluri appointed as CEO, President, and Board member, effective Jan 18, 2023.","Separation agreement conditioned on release of claims and compliance with confidentiality and non-disparagement covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-01-18T23:59:59+00:00|322866"}